AIDS Healthcare Foundation (AHF) calls on President Biden to support a proposal for an expanded waiver on intellectual property (IP) rights for COVID-19 treatments and diagnostics currently being advanced at the World Trade Organization (WTO) despite opposition in the U.S. Congress.
“Opposition to the WTO IP waiver by some members of Congress is shortsighted and misplaced. Technological protectionism and vaccine hoarding during the pandemic cost the world millions of lives and trillions of dollars, while Big Pharma made off with record-breaking profits,” said AHF President Michael Weinstein. “We urge President Biden to do the right thing in the name of global health security and public health and support the waiver. COVID-19 is clearly not over, and other pandemics are inevitable – we must put people’s lives first and be better prepared for the next global health disaster.”
About AIDS Healthcare Foundation (AHF)
AIDS Healthcare Foundation (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 1.9 million people in 46 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. We are currently the largest non-profit provider of HIV/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare
View source version on businesswire.com: https://www.businesswire.com/news/home/20240125362802/en/
Contacts
US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1 323.308.1833 work +1 323.791.5526 mobile
gedk@aidshealth.org
Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@aidshealth.org
